Vermont Tech Scene
SEE OTHER BRANDS

Exploring the science and technology news of Vermont

Vermont Tech Scene: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vermont Tech Scene.

Press releases published on May 27, 2025

Xtract One Teams Up with MLB’s Colorado Rockies to Deploy SmartGateway at Coors Field, Bringing Frictionless Screening to Fans this Season

Xtract One Teams Up with MLB’s Colorado Rockies to Deploy SmartGateway at Coors Field, Bringing Frictionless Screening to Fans this Season

TORONTO, May 27, 2025 (GLOBE NEWSWIRE) -- Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced it has signed an agreement with the Colorado Rockies (“Rockies”) of Major League Baseball (MLB) to use …

GlycoEra AG Raises $130 Million to Advance Novel Pipeline of Extracellular Protein Degraders for the Treatment of Autoimmune Diseases

GlycoEra AG Raises $130 Million to Advance Novel Pipeline of Extracellular Protein Degraders for the Treatment of Autoimmune Diseases

Financing led by Novo Holdings with significant support from world-class group of existing and new investors Proceeds from financing to support development of first-in-class IgG4-targeted protein degrader program through clinical proof-of-concept and the …

Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 46th Annual Global Healthcare Conference

Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 46th Annual Global Healthcare Conference

BOSTON and SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological or …

EyePoint Completes Enrollment in Pivotal Phase 3 LUGANO Trial of DURAVYU™ for Treatment of Wet Age-Related Macular Degeneration

EyePoint Completes Enrollment in Pivotal Phase 3 LUGANO Trial of DURAVYU™ for Treatment of Wet Age-Related Macular Degeneration

– Over 400 patients enrolled and randomized over a seven-month period, driven by strong physician and patient interest – –  LUCIA pivotal Phase 3 trial continues rapid enrollment pace with 60% of patients randomized; enrollment completion expected in 3Q …

NewGen Announces Strategic Expansion with Services Tailored for Indian Medical Tourists

NewGen Announces Strategic Expansion with Services Tailored for Indian Medical Tourists

BANGKOK, May 27, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that …

Castellum, Inc. Announces Information Concerning 2025 Annual Stockholders Meeting

Castellum, Inc. Announces Information Concerning 2025 Annual Stockholders Meeting

VIENNA, Va., May 27, 2025 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-American: CTM) ("Castellum" or "CTM"), a cybersecurity, electronic warfare, and software engineering services company focused on the federal government, reminds stockholders that its 2025 …

Strüngmann Award ehrt herausragende Life-Science-Unternehmerinnen und Unternehmer aus der DACH-Region und gibt 2025 Finalisten bekannt

Strüngmann Award ehrt herausragende Life-Science-Unternehmerinnen und Unternehmer aus der DACH-Region und gibt 2025 Finalisten bekannt

Die diesjährigen Finalistinnen und Finalisten überzeugten durch unternehmerische Exzellenz und großes Innovationspotenzial ihrer therapeutischen Ansätze über unterschiedliche wissenschaftliche Fachrichtungen hinweg Das Gewinnerteam wird am 3. Juli 2025 …

Strüngmann Award Committee Announces 2025 Finalists Recognizing Outstanding Life Science Entrepreneurs in the DACH Region

Strüngmann Award Committee Announces 2025 Finalists Recognizing Outstanding Life Science Entrepreneurs in the DACH Region

The selected finalists have demonstrated entrepreneurial execution and translational potential for a range of scientific approaches The winner(s) will be officially announced on July 3, 2025, and will receive an EUR 100,000 cash prize Munich, Germany, May …

Juri Biosciences, a TCG Labs Soleil Portfolio Company, and EpimAb Biotherapeutics Enter into a Worldwide Licensing Agreement for KLK2-Directed T-Cell Engager in Metastatic Prostate Cancer

Juri Biosciences, a TCG Labs Soleil Portfolio Company, and EpimAb Biotherapeutics Enter into a Worldwide Licensing Agreement for KLK2-Directed T-Cell Engager in Metastatic Prostate Cancer

SAN FRANCISCO and SHANGHAI, May 27, 2025 (GLOBE NEWSWIRE) -- TCG Labs Soleil, a venture firm integrating dedicated capital with an in-house biotech R…

仙境传说之约定好的冒险 (Ragnarok: Promised Adventure, Tentative English Title)  Received an ISBN Code by Chinese Government

仙境传说之约定好的冒险 (Ragnarok: Promised Adventure, Tentative English Title) Received an ISBN Code by Chinese Government

Seoul, South Korea, May 27, 2025 (GLOBE NEWSWIRE) -- GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and publisher of online and mobile games, announced that 仙境传说之约定好的冒险 (Ragnarok: Promised Adventure, tentative English title), an …

Malaysia AI Workshop Led by Strategic Partner Spotlights Strong Demand for GPTBots’ Enterprise AI Solutions

Malaysia AI Workshop Led by Strategic Partner Spotlights Strong Demand for GPTBots’ Enterprise AI Solutions

KUALA LUMPUR, Malaysia, May 27, 2025 (GLOBE NEWSWIRE) -- A high-impact AI workshop hosted by Zanroo Malaysia Sdn. Bhd., a key strategic partner of GPTBots.ai, highlighted strong enterprise demand for practical AI solutions in Southeast Asia and …

The Eclipse Foundation and the Adoptium Working Group Announce the Latest Eclipse Temurin Open Source Java SE Runtime

The Eclipse Foundation and the Adoptium Working Group Announce the Latest Eclipse Temurin Open Source Java SE Runtime

BRUSSELS, May 27, 2025 (GLOBE NEWSWIRE) -- The Eclipse Foundation, a leading open source foundation, in collaboration with the Adoptium Working Group, today announced the latest release of Eclipse Temurin’s Java SE runtime. As organisations around the …

ITM Secures Up to $262.5m in Non-dilutive Debt Financing with Blue Owl Managed Funds

ITM Secures Up to $262.5m in Non-dilutive Debt Financing with Blue Owl Managed Funds

Debt capital to support commercial readiness and potential U.S. launch of n.c.a. 177Lu-edotreotide (ITM-11), following positive Phase 3 results Flexible funding structure enables continued advancement of ITM’s targeted radiopharmaceutical pipeline and …

OwlTing Group Unveils AI-Powered OwlPay® Harbor™ for Stablecoin On/Off-Ramping

OwlTing Group Unveils AI-Powered OwlPay® Harbor™ for Stablecoin On/Off-Ramping

ARLINGTON, Va., May 27, 2025 (GLOBE NEWSWIRE) -- OwlTing Group (the “Company”), a global blockchain fintech company, today announced an integration of AI features into its payment API infrastructure, OwlPay® Harbor™ (the “Platform”). This AI-driven …

 Epitopea Announces Nature Cancer Paper on Novel Immunotherapy Targets in Melanoma and NSCLC

Epitopea Announces Nature Cancer Paper on Novel Immunotherapy Targets in Melanoma and NSCLC

MONTREAL and CAMBRIDGE, United Kingdom, May 27, 2025 (GLOBE NEWSWIRE) -- Epitopea, a transatlantic cancer immunotherapy company, and Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal, a leading Canadian research …

Epitopea annonce un article dans Nature Cancer sur de nouvelles cibles d'immunothérapie dans le mélanome et le cancer du poumon non à petites cellules (NSCLC)

Epitopea annonce un article dans Nature Cancer sur de nouvelles cibles d'immunothérapie dans le mélanome et le cancer du poumon non à petites cellules (NSCLC)

MONTRÉAL et CAMBRIDGE, Royaume-Uni, 27 mai 2025 (GLOBE NEWSWIRE) -- Epitopea, une société transatlantique spécialisée en immunothérapie des cancers, et l'Institut de recherche en immunologie et en cancérologie (IRIC) de l'Université de Montréal, une …

C4X Discovery receives latest milestone payment from Sanofi

C4X Discovery receives latest milestone payment from Sanofi

€8 million milestone payment triggered by pre-clinical progression in oral IL-17A inhibitor programme 27 May 2025 – C4X Discovery Holdings Ltd (“C4XD”), a pioneering Drug Discovery company, today announces that it has received a milestone payment of €8 …

big xyt Wins WatersTechnology Asia Award 2025 for Best Analytics Solution

big xyt Wins WatersTechnology Asia Award 2025 for Best Analytics Solution

London, May 27, 2025 (GLOBE NEWSWIRE) -- big xyt, a leading independent provider of high-quality trade data and analytics, is proud to announce that it has been named winner for Best Analytics Solution at the WatersTechnology Asia Awards 2025. This …

Mavenir’s Converged Packet Core Solution Set to Transform Tampnet’s Global 4G/5G Mobile Network

Mavenir’s Converged Packet Core Solution Set to Transform Tampnet’s Global 4G/5G Mobile Network

READING, United Kingdom, May 27, 2025 (GLOBE NEWSWIRE) -- Mavenir, the cloud-native network infrastructure provider, today announced that it has been selected as a key technology partner by Tampnet – a global leader in offshore, high-capacity, low-latency …

Salvia BioElectronics Secures $60M in Oversubscribed Series B  to Bring its Pioneering Migraine Therapy to Market

Salvia BioElectronics Secures $60M in Oversubscribed Series B to Bring its Pioneering Migraine Therapy to Market

Series B funding round led by Innovation Industries, with participation from Invest-NL, EIC Fund, and existing investors Inkef, Panakès Partners, SHS Capital, Dolby Family  Ventures, Brabant Development Agency (BOM) and Thuja Capital. Proceeds will fund …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service